91 related articles for article (PubMed ID: 279357)
1. Delayed hypersensitivity skin reactions in the induction phase of remission in acute non lymphoid leukemias.
Vu Van H; Fiere D; Doillon M; Martin C; Coiffier B; Revol L
Biomedicine; 1978; 28(3):166-9. PubMed ID: 279357
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of delayed-hypersensitivity skin tests and rosette studies in acute non-lymphoid leukemias].
Vu Van H; Révillard JP; Brochier J; Samarut C; Fière D; Révol L
Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):413-22. PubMed ID: 314098
[TBL] [Abstract][Full Text] [Related]
3. Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemia.
Frydecka I; Becker M
Arch Immunol Ther Exp (Warsz); 1980; 28(4):645-7. PubMed ID: 6935989
[TBL] [Abstract][Full Text] [Related]
4. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune reactions in human acute leukemia.
Herberman RB
Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
[No Abstract] [Full Text] [Related]
6. The relationship of cellular immunity to prognosis in acute leukemia.
Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K
Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590
[TBL] [Abstract][Full Text] [Related]
7. [Can the course of an acute leukemia be predicted?].
Heim M; Albert WK; Schäfer W; Wahrendorf J; Queisser W
Med Klin; 1981 Sep; 76(19):537-40. PubMed ID: 6944596
[TBL] [Abstract][Full Text] [Related]
8. Immunologic studies in acute leukemia.
Santos GW; Mullins GM; Bias WB; Anderson PN; Graziano KD; Klein DL; Burke PJ
Natl Cancer Inst Monogr; 1973 Jun; 37():69-75. PubMed ID: 4268325
[No Abstract] [Full Text] [Related]
9. Overshoot phenomenon of phytohemagglutinin response after chemotherapy and its relationship to remission in acute non-lymphocytic leukemia.
Harada M; Mori T; Kodo H; Ishino C; Matsue K; Hattori K
Gan; 1979 Feb; 70(1):89-93. PubMed ID: 286667
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in adult patients with acute leukemia.
Arimori S; Nagao T
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):411-7. PubMed ID: 6242082
[TBL] [Abstract][Full Text] [Related]
11. [Acute leukemia. Case material and therapeutic results].
Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
[TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
13. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
15. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.
Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Blood Cells; 1983; 9(3):501-14. PubMed ID: 6586210
[TBL] [Abstract][Full Text] [Related]
16. [Disorders of humoral and cellular immunity in acute adult leukemia].
Steruská M; Sakalová A; Gazová S; Drobná V; Chabronová I; Hrubisko M
Vnitr Lek; 1979 Jan; 25(1):29-33. PubMed ID: 283625
[No Abstract] [Full Text] [Related]
17. Host-defence mechanisms in surgical patients: a correlative study of the delayed hypersensitivity skin-test response, granulocyte function and sepsis.
Christou NV
Can J Surg; 1985 Jan; 28(1):39-46, 49. PubMed ID: 3971221
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
Hirano M; Uetani T; Morita A; Sako F; Koie K
Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
[No Abstract] [Full Text] [Related]
20. [Factors related to prognosis and relapse in acute myelomonocytic and monocytic leukemias (M4 and M5)].
Koyama A; Shirakawa C; Masaki H; Horiuchi F; Hamazaki H; Fujimoto T; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1990 Nov; 31(11):1787-93. PubMed ID: 2287062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
